Tignanelli, C. J., Ingraham, N. E., Sparks, M. A., Reilkoff, R., Bezdicek, T., Benson, B., … Puskarich, M. A. (2020). Antihypertensive drugs and risk of COVID-19? Lancet Respir Med, 8(5), e30–e31. https://doi.org/10.1016/S2213-2600(20)30153-3

Tignanelli, Christopher J., Nicholas E. Ingraham, Matthew A. Sparks, Ronald Reilkoff, Tamara Bezdicek, Bradley Benson, Timothy Schacker, Jeffrey G. Chipman, and Michael A. Puskarich. “Antihypertensive drugs and risk of COVID-19?” Lancet Respir Med 8, no. 5 (May 2020): e30–31. https://doi.org/10.1016/S2213-2600(20)30153-3.

Tignanelli CJ, Ingraham NE, Sparks MA, Reilkoff R, Bezdicek T, Benson B, et al. Antihypertensive drugs and risk of COVID-19? Lancet Respir Med. 2020 May;8(5):e30–1.

Tignanelli, Christopher J., et al. “Antihypertensive drugs and risk of COVID-19?” Lancet Respir Med, vol. 8, no. 5, May 2020, pp. e30–31. Pubmed, doi:10.1016/S2213-2600(20)30153-3.

Tignanelli CJ, Ingraham NE, Sparks MA, Reilkoff R, Bezdicek T, Benson B, Schacker T, Chipman JG, Puskarich MA. Antihypertensive drugs and risk of COVID-19? Lancet Respir Med. 2020 May;8(5):e30–e31.